Rosa Negron Munoz
Child & Adolescent Psychiatry · Lakeland, FLNPI 1578720165
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by H. Lundbeck A S at 34.5% of the total. 2025 is the largest year on record at $22,402, more than ten times the $1,054 reported in 2019. Among child & adolescent psychiatry clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 416 payments — averaging $93.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- H. Lundbeck A S$13K
- Alkermes, Inc.$10K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$8K
- Otsuka America Pharmaceutical, Inc.$1K
- AbbVie$1K
- Johnson & Johnson$659
- plus $3K from 16 others
Across 101 payments — averaging $6800.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Corium, LLC$341K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$202K
- AbbVie$107K
- Janssen Research & Development, LLC$21K
- Avanir Pharmaceuticals, Inc.$11K
- Sage Therapeutics, LLC$3K
- plus $2K from 1 others
What the payments were for
- Consulting fees$8102%
- Speaking & faculty fees$21,89056%
- Travel & lodging$8,33221%
- Food & beverage$7,67820%
- Education$470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| H. Lundbeck A S | 1 | $13,390 |
| Alkermes, Inc. | 24 | $10,307 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 33 | $8,208 |
| Otsuka America Pharmaceutical, Inc. | 25 | $1,491 |
| AbbVie(2 entities) | 86 | $1,293 |
| Johnson & Johnson | 21 | $659 |
| Ironshore Pharmaceuticals Inc. | 74 | $627 |
| Sunovion Pharmaceuticals Inc. | 26 | $477 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $428 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $351 |
| Tris Pharma Inc | 14 | $278 |
| Neuronetics, Inc. | 6 | $235 |
| Axsome Therapeutics, Inc. | 8 | $229 |
| Collegium Pharmaceutical, Inc. | 25 | $174 |
| Lundbeck LLC | 8 | $160 |
| Corium, LLC | 14 | $128 |
| E.r. Squibb & Sons, L.L.C. | 1 | $76 |
| Vanda Pharmaceuticals Inc. | 3 | $72 |
| Tempus AI, Inc | 2 | $64 |
| Noven Therapeutics, LLC | 3 | $50 |
| Shire North American Group Inc | 2 | $42 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$39,628
- REXULTI$21,620
- SPRAVATO$341
- ABILIFY MAINTENA$120
- VRAYLAR$118
How this compares
$38,757 in reported general payments places this provider in the 95th percentile of 206 child & adolescent psychiatry providers in Florida.
See all child & adolescent psychiatry providers in Florida →
Other child & adolescent psychiatry in Lakeland
- Aarti PatelLakeland$4K
- Craig KuninsGulfport$265K
- Elias SarkisGainesville$169K
- Jeffrey AlvaroSt Petersburg$87K
- Sean HoranMiami$17K
- Rachel AgustinesLargo$16K
- Carlos BorgeSarasota$15K
- Justin SpoonerPonte Vedra Beach$12K
- Bhaskar RajuOrlando$11K
- Americo PadillaMiami$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.